Can C4d Immunostaining on Endomyocardial Biopsies Be Considered a Prognostic Biomarker in Heart Transplant Recipients? (Q58004270)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 October 2010
edit
Language Label Description Also known as
English
Can C4d Immunostaining on Endomyocardial Biopsies Be Considered a Prognostic Biomarker in Heart Transplant Recipients?
scientific article published on 01 October 2010

    Statements

    Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit